CURE Epilepsy awards grants for novel research projects that address finding the cures for epilepsy and address the goal of “no seizures, no side-effects.”
Scientific Advisory Council (SAC) members may not apply for funding from or participate in grant funding recommendations for CURE Epilepsy while serving on the SAC.
The Taking Flight Award (1.5 years / $125,000) seeks to promote the careers of early-career investigators to allow them to develop an independent research focus.
You must fall into one of the following categories to be eligible for the Taking Flight Award:
International applicants are welcome; you do not have to be a US citizen or working in the US to apply for this award. All materials must be submitted in English.
Requests may be made for up to $125,000 for eighteen months. Funding requests may include salary support for the PI, technical staff and/or collaborators; supplies, animal costs, publication fees etc.; and travel to an epilepsy-related conference if the PI is presenting his/her CURE Epilepsy-funded research. Funds are not to be used to purchase equipment. Indirect costs are not supported.
| Activity | Approximate Date |
| Open Call for Letters of Intent | Monday, November 24, 2025 |
| Letter of Intent Deadline | Tuesday, January 6, 2026 |
| Full Proposal Invitations | Tuesday, February 17, 2026 |
| Full Proposal Deadline | Tuesday, March 24, 2026 |
| Anticipated Award Notification | End of July 2026 |
| Anticipated Project Start Date | Tuesday, September 1, 2026 |
The Rare Epilepsy Partnership Award (1 year / $100,000) will support the development of necessary research tools, techniques, model systems, and data collection platforms to stimulate and accelerate research on rare epilepsies. Each award will be co-funded by CURE Epilepsy and one or more of the rare epilepsy advocacy groups (partners) identified in the Request For Proposals. Applications must focus on one or more of the specific rare epilepsies that are represented by each group as well as address CURE Epilepsy’s mission to cure epilepsy.
FOR RESEARCHERS:
FOR PARTNER GROUPS:
FOR RESEARCHERS:
This award is available to both established and early-career investigators. Early career investigators must have a mentor committed to advising the applicant. A clearly articulated mentorship statement from the mentor must be submitted along with the application. See RFP for details.
FOR PARTNER GROUPS:
CURE Epilepsy will prioritize potential partners that a) do not already have grant funding and management capabilities, b) have a scientific advisor(s) to consult on research priorities, c) can provide three specific research priorities, d) can nominate at least one person to participate in the grant development and review process and e) have available or demonstrate the potential to raise $55,000. CURE Epilepsy encourages all interested partners to apply but will prioritize those that we did not partner with in previous years.
FOR RESEARCHERS:
Funding requests must be itemized and based on specific, milestone-defined scientific aims. Requests may be made for up to a maximum of $100,000 paid over 1 year. CURE Epilepsy reserves the right to fund only select specific aims or stage funding of proposals based on the achievement of milestones. Budgets may include salary support for the Principal Investigator (PI), technical staff and/or co-PIs, supplies, animal costs, vendor costs, limited equipment cost, and travel to an epilepsy-related conference only if the PI is presenting his/her CURE Epilepsy-funded research. Indirect costs are not supported.
FOR PARTNER GROUPS:
Partner organizations contribute $55,000 to a funded grant specific to their rare epilepsy ($50,000 in grant funding, $5,000 in administrative costs).
FOR RESEARCHERS:
| Activity | Approximate Date |
| Request for Proposals Opens | Tuesday, May 12, 2026 |
| Letter of Intent Deadline | Tuesday, June 9, 2026 |
| Full Application Invitations | Monday, July 27, 2026 |
| Full Application Deadline | Tuesday, September 1, 2026 |
| Anticipated Awardee Notification | December 2026 |
| Anticipated Project Start Date | Spring 2027 |
FOR PARTNER GROUPS:
| Activity | Approximate Date |
| Registration Form Released to Rare Groups | Tuesday, January 16, 2026 |
| Partnership Registration Form Due | Tuesday, February 17, 2026 |
| Groups Are Informed of Selection | Friday, February 27, 2026 |
CURE Epilepsy’s research vision is set by the CURE Epilepsy Board of Directors, Scientific Advisory Council, and CURE Epilepsy Research Team.
RFPs are born out of CURE Epilepsy’s Strategic Vision and outline the research topic areas and requirements for the grant year.
LOIs are short letters from potential CURE Epilepsy grantees that succinctly and clearly describe their proposed research project and its relevance to CURE Epilepsy’s mission.
LOIs are reviewed and scored by the Research Team and scientific peers by criteria outlined in the RFPs.
Applicants whose LOIs are invited will submit full grant proposals that contain detailed scientific and budget information for the proposed CURE Epilepsy project.
Each full grant proposal is reviewed by three external scientific reviewers and a person with lived experience of epilepsy. People with lived experience ensure that the stakeholder point of view is critically represented in the grant review process.
Scientific reviewers are assembled for each grant mechanism and each grant review cycle. Applications are then discussed amongst the reviewers and CURE Epilepsy Research Team and scored.
Applications are discussed with the CURE Epilepsy Research Committee, which is made up of CURE Epilepsy Board members and volunteers, to ensure alignment with CURE Epilepsy’s mission. Funding recommendations are then developed and presented to the CURE Epilepsy Board of Directors.
The CURE Epilepsy Board of Directors has final approval of all grants that are funded by CURE Epilepsy each cycle.